Tissue Regenix Group plc (AIM:TRX)

Tissue Regenix Group Revenue

Tissue Regenix Group had revenue of $16.40M USD in the half year ending June 30, 2024, with 38.58% growth. This brings the company's revenue in the last twelve months to $31.80M, up 18.92% year-over-year. In the year 2023, Tissue Regenix Group had annual revenue of $29.49M with 20.50% growth.

• Revenue (ttm): $31.80M
• Revenue Growth: +18.92%
• P/S Ratio: 1.26
• Revenue / Employee: $387.77K
• Employees: 82
• Market Cap: 32.06M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	29.49M	5.02M	20.50%
Dec 31, 2022	24.48M	4.73M	23.95%
Dec 31, 2021	19.75M	3.27M	19.87%
Dec 31, 2020	16.47M	3.44M	26.39%
Dec 31, 2019	13.03M	1.41M	12.17%